nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—Masoprocol—ALOX5—atherosclerosis	0.0529	1	CrCbGaD
Dobutamine—Skin exfoliation—Niacin—atherosclerosis	0.0192	0.0698	CcSEcCtD
Dobutamine—Angina pectoris—Niacin—atherosclerosis	0.0123	0.0447	CcSEcCtD
Dobutamine—Angina pectoris—Pravastatin—atherosclerosis	0.0121	0.044	CcSEcCtD
Dobutamine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00964	0.0351	CcSEcCtD
Dobutamine—Palpitations—Ezetimibe—atherosclerosis	0.00887	0.0323	CcSEcCtD
Dobutamine—Chest pain—Lovastatin—atherosclerosis	0.00871	0.0317	CcSEcCtD
Dobutamine—Chest pain—Ezetimibe—atherosclerosis	0.00854	0.0311	CcSEcCtD
Dobutamine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00817	0.0297	CcSEcCtD
Dobutamine—Chest pain—Simvastatin—atherosclerosis	0.00814	0.0296	CcSEcCtD
Dobutamine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00802	0.0292	CcSEcCtD
Dobutamine—Palpitations—Niacin—atherosclerosis	0.00776	0.0283	CcSEcCtD
Dobutamine—Thrombocytopenia—Simvastatin—atherosclerosis	0.00764	0.0278	CcSEcCtD
Dobutamine—Dyspnoea—Lovastatin—atherosclerosis	0.00744	0.0271	CcSEcCtD
Dobutamine—Chest pain—Pravastatin—atherosclerosis	0.00736	0.0268	CcSEcCtD
Dobutamine—Dyspnoea—Ezetimibe—atherosclerosis	0.0073	0.0266	CcSEcCtD
Dobutamine—Tachycardia—Niacin—atherosclerosis	0.007	0.0255	CcSEcCtD
Dobutamine—Pruritus—Rosuvastatin—atherosclerosis	0.00697	0.0254	CcSEcCtD
Dobutamine—Dyspnoea—Simvastatin—atherosclerosis	0.00696	0.0253	CcSEcCtD
Dobutamine—Thrombocytopenia—Pravastatin—atherosclerosis	0.00691	0.0252	CcSEcCtD
Dobutamine—Hypotension—Niacin—atherosclerosis	0.0067	0.0244	CcSEcCtD
Dobutamine—Dyspnoea—Niacin—atherosclerosis	0.00639	0.0233	CcSEcCtD
Dobutamine—Dyspnoea—Pravastatin—atherosclerosis	0.00629	0.0229	CcSEcCtD
Dobutamine—Headache—Rosuvastatin—atherosclerosis	0.00617	0.0225	CcSEcCtD
Dobutamine—Pruritus—Lovastatin—atherosclerosis	0.00591	0.0215	CcSEcCtD
Dobutamine—Nausea—Rosuvastatin—atherosclerosis	0.00585	0.0213	CcSEcCtD
Dobutamine—Pruritus—Ezetimibe—atherosclerosis	0.00579	0.0211	CcSEcCtD
Dobutamine—Pruritus—Simvastatin—atherosclerosis	0.00552	0.0201	CcSEcCtD
Dobutamine—Headache—Lovastatin—atherosclerosis	0.00523	0.019	CcSEcCtD
Dobutamine—Headache—Ezetimibe—atherosclerosis	0.00513	0.0187	CcSEcCtD
Dobutamine—Pruritus—Niacin—atherosclerosis	0.00507	0.0185	CcSEcCtD
Dobutamine—Pruritus—Pravastatin—atherosclerosis	0.00499	0.0182	CcSEcCtD
Dobutamine—Nausea—Lovastatin—atherosclerosis	0.00496	0.018	CcSEcCtD
Dobutamine—Headache—Simvastatin—atherosclerosis	0.00489	0.0178	CcSEcCtD
Dobutamine—Nausea—Ezetimibe—atherosclerosis	0.00486	0.0177	CcSEcCtD
Dobutamine—Nausea—Simvastatin—atherosclerosis	0.00464	0.0169	CcSEcCtD
Dobutamine—Headache—Niacin—atherosclerosis	0.00449	0.0163	CcSEcCtD
Dobutamine—Headache—Pravastatin—atherosclerosis	0.00442	0.0161	CcSEcCtD
Dobutamine—Nausea—Niacin—atherosclerosis	0.00426	0.0155	CcSEcCtD
Dobutamine—Nausea—Pravastatin—atherosclerosis	0.00419	0.0153	CcSEcCtD
Dobutamine—ADRB1—Signaling by GPCR—CX3CL1—atherosclerosis	0.000776	0.00115	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CX3CR1—atherosclerosis	0.000774	0.00115	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CASR—atherosclerosis	0.000774	0.00115	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—AGT—atherosclerosis	0.000771	0.00115	CbGpPWpGaD
Dobutamine—COMT—Metabolism—HMGCR—atherosclerosis	0.000765	0.00114	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CX3CL1—atherosclerosis	0.000759	0.00113	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HRH1—atherosclerosis	0.000757	0.00113	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—APOE—atherosclerosis	0.000755	0.00112	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CAV1—atherosclerosis	0.000748	0.00111	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—APOA1—atherosclerosis	0.000747	0.00111	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HRH1—atherosclerosis	0.00074	0.0011	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CNR2—atherosclerosis	0.000736	0.00109	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CG—atherosclerosis	0.00073	0.00109	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000721	0.00107	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CNR2—atherosclerosis	0.00072	0.00107	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000706	0.00105	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PPARG—atherosclerosis	0.000705	0.00105	CbGpPWpGaD
Dobutamine—CA2—Metabolism—HMOX1—atherosclerosis	0.000698	0.00104	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—INS—atherosclerosis	0.000691	0.00103	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CG—atherosclerosis	0.000682	0.00101	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ABCA1—atherosclerosis	0.000682	0.00101	CbGpPWpGaD
Dobutamine—CA2—Metabolism—APOB—atherosclerosis	0.000668	0.000994	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—AGT—atherosclerosis	0.000667	0.000992	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PPARG—atherosclerosis	0.000658	0.000978	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—AGT—atherosclerosis	0.000653	0.000971	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GSTM1—atherosclerosis	0.00065	0.000967	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—INS—atherosclerosis	0.000645	0.00096	CbGpPWpGaD
Dobutamine—CA2—Metabolism—LPL—atherosclerosis	0.000638	0.000949	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—ALB—atherosclerosis	0.000634	0.000942	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCL3—atherosclerosis	0.000633	0.000941	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—EDNRA—atherosclerosis	0.00063	0.000937	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CCR2—atherosclerosis	0.00063	0.000937	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GPX1—atherosclerosis	0.000623	0.000926	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCL3—atherosclerosis	0.000619	0.00092	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—F2—atherosclerosis	0.000616	0.000917	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—EDNRA—atherosclerosis	0.000616	0.000917	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CCR2—atherosclerosis	0.000616	0.000917	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GHRL—atherosclerosis	0.000614	0.000913	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CD36—atherosclerosis	0.000606	0.000902	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—NOS3—atherosclerosis	0.000606	0.000901	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—F2—atherosclerosis	0.000603	0.000897	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GHRL—atherosclerosis	0.000601	0.000893	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOA4—atherosclerosis	0.000594	0.000883	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ALB—atherosclerosis	0.000591	0.00088	CbGpPWpGaD
Dobutamine—COMT—Metabolism—HMOX1—atherosclerosis	0.000585	0.00087	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOA4—atherosclerosis	0.000581	0.000864	CbGpPWpGaD
Dobutamine—CA2—Metabolism—MTHFR—atherosclerosis	0.000575	0.000855	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—EDNRA—atherosclerosis	0.000572	0.000851	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCR2—atherosclerosis	0.000572	0.000851	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.00057	0.000848	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—NOS3—atherosclerosis	0.000566	0.000842	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PPARA—atherosclerosis	0.000564	0.000838	CbGpPWpGaD
Dobutamine—COMT—Metabolism—APOB—atherosclerosis	0.00056	0.000833	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—EDNRA—atherosclerosis	0.00056	0.000832	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCR2—atherosclerosis	0.00056	0.000832	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000558	0.00083	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GHRL—atherosclerosis	0.000558	0.000829	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PTGS2—atherosclerosis	0.000554	0.000824	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—CCL2—atherosclerosis	0.000549	0.000817	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCL4—atherosclerosis	0.000547	0.000814	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AGT—atherosclerosis	0.000546	0.000812	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GHRL—atherosclerosis	0.000545	0.000811	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GSTM1—atherosclerosis	0.000545	0.00081	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—KNG1—atherosclerosis	0.000539	0.000802	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CCL2—atherosclerosis	0.000537	0.000799	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000536	0.000797	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCL4—atherosclerosis	0.000535	0.000796	CbGpPWpGaD
Dobutamine—CA2—Metabolism—APOE—atherosclerosis	0.000535	0.000796	CbGpPWpGaD
Dobutamine—COMT—Metabolism—LPL—atherosclerosis	0.000535	0.000795	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CAV1—atherosclerosis	0.00053	0.000788	CbGpPWpGaD
Dobutamine—CA2—Metabolism—APOA1—atherosclerosis	0.000529	0.000786	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—KNG1—atherosclerosis	0.000527	0.000784	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000524	0.000779	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GPX1—atherosclerosis	0.000522	0.000776	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PTGS2—atherosclerosis	0.000517	0.00077	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOA2—atherosclerosis	0.000511	0.00076	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CD36—atherosclerosis	0.000508	0.000756	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOA2—atherosclerosis	0.0005	0.000744	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—KNG1—atherosclerosis	0.000489	0.000728	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—UTS2—atherosclerosis	0.000488	0.000725	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AGTR1—atherosclerosis	0.000486	0.000724	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CG—atherosclerosis	0.000483	0.000718	CbGpPWpGaD
Dobutamine—COMT—Metabolism—MTHFR—atherosclerosis	0.000481	0.000716	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—KNG1—atherosclerosis	0.000479	0.000712	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—UTS2—atherosclerosis	0.000477	0.000709	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AGTR1—atherosclerosis	0.000476	0.000708	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPARA—atherosclerosis	0.000472	0.000703	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CX3CR1—atherosclerosis	0.000467	0.000695	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CASR—atherosclerosis	0.000467	0.000695	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PPARG—atherosclerosis	0.000466	0.000693	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CX3CL1—atherosclerosis	0.000458	0.000682	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AGT—atherosclerosis	0.000457	0.00068	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CX3CR1—atherosclerosis	0.000457	0.00068	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CASR—atherosclerosis	0.000457	0.00068	CbGpPWpGaD
Dobutamine—CA2—Metabolism—INS—atherosclerosis	0.000457	0.00068	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—EDN1—atherosclerosis	0.000454	0.000676	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CCL5—atherosclerosis	0.000451	0.00067	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CX3CL1—atherosclerosis	0.000448	0.000667	CbGpPWpGaD
Dobutamine—COMT—Metabolism—APOE—atherosclerosis	0.000448	0.000667	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—EDN1—atherosclerosis	0.000444	0.000661	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CAV1—atherosclerosis	0.000444	0.000661	CbGpPWpGaD
Dobutamine—COMT—Metabolism—APOA1—atherosclerosis	0.000443	0.000659	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CCL5—atherosclerosis	0.000441	0.000656	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CNR2—atherosclerosis	0.000435	0.000646	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—CXCL8—atherosclerosis	0.000434	0.000646	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—MMP3—atherosclerosis	0.000434	0.000645	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000428	0.000637	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CNR2—atherosclerosis	0.000425	0.000632	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CXCL8—atherosclerosis	0.000425	0.000632	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—MMP3—atherosclerosis	0.000424	0.000631	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000419	0.000623	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ALB—atherosclerosis	0.000419	0.000623	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—EDN1—atherosclerosis	0.000412	0.000613	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCL5—atherosclerosis	0.000409	0.000609	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CG—atherosclerosis	0.000405	0.000602	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	0.000403	0.0006	CbGpPWpGaD
Dobutamine—CA2—Metabolism—NOS3—atherosclerosis	0.000401	0.000596	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	0.0004	0.000595	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPARG—atherosclerosis	0.00039	0.000581	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PRKCG—atherosclerosis	0.000389	0.000579	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VWF—atherosclerosis	0.000387	0.000576	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOC3—atherosclerosis	0.000385	0.000573	CbGpPWpGaD
Dobutamine—COMT—Metabolism—INS—atherosclerosis	0.000383	0.00057	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LDLR—atherosclerosis	0.000383	0.000569	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	0.000381	0.000566	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VWF—atherosclerosis	0.000379	0.000564	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AGT—atherosclerosis	0.000377	0.000561	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOC3—atherosclerosis	0.000377	0.00056	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LDLR—atherosclerosis	0.000374	0.000557	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCL3—atherosclerosis	0.000374	0.000556	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	0.000369	0.000548	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PTGS2—atherosclerosis	0.000367	0.000545	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCL3—atherosclerosis	0.000366	0.000544	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NCF1—atherosclerosis	0.000358	0.000532	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ALB—atherosclerosis	0.000351	0.000522	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NCF1—atherosclerosis	0.00035	0.000521	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—F2—atherosclerosis	0.000348	0.000518	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AGT—atherosclerosis	0.000342	0.000509	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—F2—atherosclerosis	0.000341	0.000507	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	0.000338	0.000503	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCR2—atherosclerosis	0.000338	0.000503	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CYBA—atherosclerosis	0.000336	0.0005	CbGpPWpGaD
Dobutamine—COMT—Metabolism—NOS3—atherosclerosis	0.000336	0.000499	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AGT—atherosclerosis	0.000335	0.000498	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000333	0.000496	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCR2—atherosclerosis	0.000331	0.000492	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	0.000331	0.000492	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PARP1—atherosclerosis	0.000329	0.00049	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PLAT—atherosclerosis	0.000329	0.00049	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GHRL—atherosclerosis	0.000329	0.00049	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CYBA—atherosclerosis	0.000329	0.00049	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000326	0.000485	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PARP1—atherosclerosis	0.000322	0.000479	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GHRL—atherosclerosis	0.000322	0.000479	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PLAT—atherosclerosis	0.000322	0.000479	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—F2—atherosclerosis	0.000316	0.00047	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—F2—atherosclerosis	0.000309	0.00046	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTGS2—atherosclerosis	0.000307	0.000457	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000303	0.00045	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000296	0.00044	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KNG1—atherosclerosis	0.000289	0.00043	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	0.000287	0.000427	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KNG1—atherosclerosis	0.000283	0.000421	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	0.000282	0.000419	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	0.000281	0.000418	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PLG—atherosclerosis	0.00028	0.000417	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—AKT1—atherosclerosis	0.000279	0.000414	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	0.000276	0.00041	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PLG—atherosclerosis	0.000274	0.000407	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	0.000265	0.000394	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—AKT1—atherosclerosis	0.00026	0.000387	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	0.000259	0.000386	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MMP3—atherosclerosis	0.000256	0.000381	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF2—atherosclerosis	0.000255	0.000379	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MMP3—atherosclerosis	0.000251	0.000373	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF2—atherosclerosis	0.000249	0.000371	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOB—atherosclerosis	0.000248	0.000368	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000245	0.000365	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EDN1—atherosclerosis	0.000244	0.000362	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOB—atherosclerosis	0.000242	0.00036	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCL5—atherosclerosis	0.000242	0.00036	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	0.00024	0.000357	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EDN1—atherosclerosis	0.000238	0.000354	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCL5—atherosclerosis	0.000236	0.000352	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LPL—atherosclerosis	0.000236	0.000352	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LPL—atherosclerosis	0.000231	0.000344	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	0.00023	0.000342	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	0.000225	0.000334	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SPP1—atherosclerosis	0.000224	0.000333	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	0.000223	0.000332	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SPP1—atherosclerosis	0.000219	0.000326	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	0.000218	0.000324	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	0.000207	0.000308	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	0.000203	0.000301	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AGT—atherosclerosis	0.000202	0.000301	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LEP—atherosclerosis	0.000198	0.000295	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOE—atherosclerosis	0.000198	0.000295	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AGT—atherosclerosis	0.000198	0.000294	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CAV1—atherosclerosis	0.000196	0.000292	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOA1—atherosclerosis	0.000196	0.000291	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOE—atherosclerosis	0.000194	0.000288	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LEP—atherosclerosis	0.000194	0.000288	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CAV1—atherosclerosis	0.000192	0.000286	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOA1—atherosclerosis	0.000192	0.000285	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ESR1—atherosclerosis	0.000189	0.000281	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—F2—atherosclerosis	0.000187	0.000278	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ESR1—atherosclerosis	0.000185	0.000275	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AKT1—atherosclerosis	0.000184	0.000274	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—F2—atherosclerosis	0.000183	0.000272	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	0.000179	0.000266	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	0.000175	0.00026	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	0.000171	0.000255	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—INS—atherosclerosis	0.000169	0.000252	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	0.000168	0.000249	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCL2—atherosclerosis	0.000167	0.000248	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—INS—atherosclerosis	0.000166	0.000246	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF1—atherosclerosis	0.000164	0.000244	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCL2—atherosclerosis	0.000163	0.000242	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF1—atherosclerosis	0.00016	0.000238	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	0.000155	0.000231	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AKT1—atherosclerosis	0.000154	0.00023	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	0.000152	0.000226	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOS3—atherosclerosis	0.000148	0.000221	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOS3—atherosclerosis	0.000145	0.000216	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	0.000132	0.000196	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	0.000129	0.000192	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	0.000127	0.000189	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6—atherosclerosis	0.000125	0.000186	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	0.000124	0.000185	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6—atherosclerosis	0.000122	0.000182	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MMP9—atherosclerosis	0.000119	0.000177	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	0.000118	0.000175	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MMP9—atherosclerosis	0.000117	0.000173	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	0.000116	0.000172	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	0.000116	0.000172	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	0.000115	0.000171	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	0.000113	0.000169	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	0.000113	0.000168	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	0.000107	0.000159	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—STAT3—atherosclerosis	0.000106	0.000158	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	0.000105	0.000156	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—STAT3—atherosclerosis	0.000104	0.000154	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	0.000101	0.00015	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	9.9e-05	0.000147	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	9.82e-05	0.000146	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	9.6e-05	0.000143	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6—atherosclerosis	7.4e-05	0.00011	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6—atherosclerosis	7.24e-05	0.000108	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT1—atherosclerosis	6.82e-05	0.000101	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT1—atherosclerosis	6.68e-05	9.93e-05	CbGpPWpGaD
